As per DelveInsight’s assessment, the Cardiac Rhythm Management Devices Market is expected to grow at an immense pace inthe coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Cardiac Rhythm Management Devices have been used, which is expected to drive the demand for Cardiac Rhythm Management Devices in the upcoming years.
DelveInsight’s “Cardiac Rhythm Management Devices Market” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Cardiac Rhythm Management Devices companies actively working in the market.
Cardiac Rhythm Management Devices Overview
Cardiac Rhythm Management Devices (CRMDs) are implantable medical devices used to manage and regulate the rhythm of the heart. These devices are primarily utilized in patients with heart rhythm disorders or arrhythmias.
Cardiac Rhythm Management Devices Market Insights
In 2022, North America is projected to hold the largest portion of the cardiac rhythm management devices market among all regions. This estimation is attributed to several crucial factors promoting growth, including the increasing prevalence of diverse heart rhythm disorders, a rise in risk factors like smoking and diabetes, a population with high disposable income, advanced healthcare infrastructure, the presence of major industry players, a surge in product development initiatives, and other contributing elements. As a result, the cardiac rhythm management devices market is anticipated to experience substantial growth in the region from 2023 to 2028.
DelveInsight Cardiac Rhythm Management Devices Market Size Analysis: The Global Cardiac Rhythm Management Devices market size is anticipated to grow by 2028 with a CAGR of 5.64% during the forecasted period (2023-2028)
To know more about why North America is leading the market growth in the Cardiac Rhythm Management Devices market, get a snapshot of the report Cardiac Rhythm Management Devices Market Trends
https://www.delveinsight.com/report-store/cardiac-rhythm-management-devices-market
Recent Developments in the Cardiac Rhythm Management Devices Market Report
- In July 2023, Abbott disclosed that the AVEIR™ dual chamber (DR) leadless pacemaker system had received approval from the US Food and Drug Administration (FDA). This innovative system stands as the world’s initial dual chamber leadless pacing system designed to address individuals experiencing abnormal or slow heart rhythms.
- In January 2023, Medtronic plc, a prominent figure in healthcare technology worldwide, obtained approval from the US Food and Drug Administration (FDA) for the Aurora EV-ICD™ MRI SureScan™ (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV™ MRI SureScan™ defibrillation lead. These devices are intended for the treatment of dangerously rapid heart rhythms that may result in sudden cardiac arrest (SCA).
- In July 2020, Abbott declared that the next iteration of their Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices has been given the green light by the US Food and Drug Administration (FDA).
- Thus, owing to such developments in the market, rapid growth will be observed in the Cardiac Rhythm Management Devices market during the forecast period
To read more about the latest highlights related to Cardiac Rhythm Management Devices, get a snapshot of the key highlights entailed in the Cardiac Rhythm Management Devices Market Forecast
Key Players in the Cardiac Rhythm Management Devices Market
Some of the key market players operating in the Cardiac Rhythm Management Devices market include- Abbott, Medtronic, Boston Scientific Corporation, Koninklijke Philips N.V, Zoll Medical Corporation, Microport Scientific Corporation, LivaNova PLC, Stryker, Nihon Kohden Corporation, Biotronik, Inc., Shree Pacetronix Ltd., OSCOR Inc., Lepu Medical Technology Co. Ltd., BPL Medical Technologies, CU Medical Systems, Inc., SCHILLER AG, Bexen Cardio, Progetti S.r.l., Vitatron, Kestra Medical Technologies, Inc., and others.
Cardiac Rhythm Management Devices Market Dynamics:
According to the American Heart Association’s 2022 report, approximately 244.1 million individuals globally were living with coronary (ischemic) heart disease in 2020. The highest prevalence rates of this disease were observed in North Africa, the Middle East, Central and South Asia, and Eastern Europe during the same year.
Data from the British Heart Foundation’s 2022 findings revealed that around 550 million people worldwide, representing 1 in 14 individuals, were living with heart and circulatory diseases in 2019. This statistic encompassed approximately 290 million women and about 260 million men. In 2019, North America recorded that cardiovascular diseases affected 4,103,135 individuals, with 1,089,947 diagnosed cases of coronary artery disease and 498,551 instances of stroke. In Asia, there were 32,376,834 reported cases of cardiovascular diseases, with 12,543,833 individuals affected by coronary artery disease and 8,111,044 people suffering from stroke.
Nevertheless, challenges arising from complications linked to diverse cardiac rhythm disorders and the rigorous regulatory approval procedures could impede the expansion of the complete market for cardiac rhythm management devices.
Scope of the Cardiac Rhythm Management Devices Market Report
- Coverage: Global
- Study Period: 2020–2028
- Cardiac Rhythm Management Devices Market Segmentation By Product Type: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) Devices
- Cardiac Rhythm Management Devices Market Segmentation By End-User: Hospitals, Cardiac Centers, and Others
- Cardiac Rhythm Management Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Cardiac Rhythm Management Devices Companies: Abbott, Medtronic, Boston Scientific Corporation, Koninklijke Philips N.V, Zoll Medical Corporation, Microport Scientific Corporation, LivaNova PLC, Stryker, Nihon Kohden Corporation, Biotronik, Inc., Shree Pacetronix Ltd., OSCOR Inc., Lepu Medical Technology Co. Ltd., BPL Medical Technologies, CU Medical Systems, Inc., SCHILLER AG, Bexen Cardio, Progetti S.r.l., Vitatron, Kestra Medical Technologies, Inc., and others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the Cardiac Rhythm Management Devices market are set to emerge as the trendsetter explore @ Cardiac Rhythm Management Devices Market Trends
Table of Contents
|
1 |
Cardiac Rhythm Management Devices Market Report Introduction |
|
2 |
Cardiac Rhythm Management Devices Market Executive summary |
|
3 |
Regulatory and Patent Analysis |
|
4 |
Cardiac Rhythm Management Devices Market Key Factors Analysis |
|
5 |
Porter’s Five Forces Analysis |
|
6 |
COVID-19 Impact Analysis on Cardiac Rhythm Management Devices Market |
|
7 |
Cardiac Rhythm Management Devices Market Layout |
|
8 |
Global Company Share Analysis – Key 3-5 Companies |
|
9 |
Company and Product Profiles |
|
10 |
Project Approach |
|
11. |
About DelveInsight |
Interested in knowing how the Cardiac Rhythm Management Devices market will grow by 2028? Click to get a snapshot of the Cardiac Rhythm Management Devices Market Analysis
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services